Key result
Minimally invasive tricuspid valve surgery provides a safe alternative for treating tricuspid valve disease, offering improved patient-reported outcomes, reduced blood loss, and earlier discharge.
Why the study?
To provide a comprehensive overview of minimally invasive tricuspid valve surgery and contextualize its role in the era of emerging transcatheter strategies.
Minimally invasive tricuspid valve surgery provides a safe and effective alternative for treating tricuspid valve disease, offering improved patient-reported outcomes and faster recovery in carefully selected patients.
Answers are grounded in this paper and cite their sources.
Minimally invasive tricuspid valve surgery may offer an alternative; leaves open the need for prospective trials to confirm safety and durability.
There has been significant growth in minimally invasive valve surgery over the past 2 decades, with novel approaches including video-assisted minithoracotomy, totally endoscopic, and robotic assisted. Outcomes of these techniques suggest that they can improve patient-reported outcomes, enhance mobility, reduce blood loss, and facilitate earlier discharge and return to work. Minimally invasive tricuspid valve surgery now provides surgeons and patients with an alternative option for treating tricuspid valve disease. These operations can be conducted safely and yield favorable outcomes with carefully selected patients. Herein, we provide a comprehensive overview of minimally invasive tricuspid valve surgery, including a summary of the current literature on minithoracotomy valve repair or replacement, beating heart, redo, and multiple-valve surgery. Finally, we contextualize how minimally invasive tricuspid valve surgery can play an important role in the era of emerging transcatheter strategies.
No takes yet. Share an insight, caveat, or question.
Hassanabad et al. (2025) conducted a review in Tricuspid valve disease. Minimally invasive tricuspid valve surgery was evaluated. Minimally invasive tricuspid valve surgery provides a safe alternative for treating tricuspid valve disease, offering improved patient-reported outcomes, reduced blood loss, and earlier discharge.
Synapse has enriched 10 related papers. Consider them for comparative context: